Zobrazeno 1 - 10
of 43
pro vyhledávání: '"June Escara‐Wilke"'
Autor:
Patricia M. Schnepp, Aqila Ahmed, June Escara-Wilke, Jinlu Dai, Greg Shelley, Jill Keller, Atsushi Mizokami, Evan T. Keller
Publikováno v:
BMC Cancer, Vol 21, Iss 1, Pp 1-14 (2021)
Abstract Background Overcoming drug resistance is critical for increasing the survival rate of prostate cancer (PCa). Docetaxel is the first cytotoxic chemotherapeutical approved for treatment of PCa. However, 99% of PCa patients will develop resista
Externí odkaz:
https://doaj.org/article/d20bcba51bc24959b570b2ddf87858d9
Publikováno v:
The Prostate.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::6b0c09eccd9d8aa6e5ec0b0e7b7338bd
https://doi.org/10.1002/pros.24584
https://doi.org/10.1002/pros.24584
Autor:
Arul M. Chinnaiyan, Felix Y. Feng, Shaomeng Wang, Nora M. Navone, Stephen R. Plymate, June Escara-Wilke, Ingrid J. Apel, Pranathi M. Krishnamurthy, Vijaya L. Dommeti, Kari Wilder-Romans, Irfan A. Asangani
Supplemental Figure Legends
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0d17423b1610ceaec708d927ec8e7334
https://doi.org/10.1158/1541-7786.22514308.v1
https://doi.org/10.1158/1541-7786.22514308.v1
Autor:
Evan T. Keller, Atsushi Mizokami, June Escara-Wilke, Jill M. Keller, Jinlu Dai, Mary Osisami, Mi Zhang
Although docetaxel is the standard of care for advanced prostate cancer, most patients develop resistance to docetaxel. Therefore, elucidating the mechanism that underlies resistance to docetaxel is critical to enhance therapeutic intervention. Minin
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::502b99677b5a84b8d8a0a654145137bd
https://doi.org/10.1158/1541-7786.c.6541078
https://doi.org/10.1158/1541-7786.c.6541078
Autor:
Arul M. Chinnaiyan, Felix Y. Feng, Shaomeng Wang, Nora M. Navone, Stephen R. Plymate, June Escara-Wilke, Ingrid J. Apel, Pranathi M. Krishnamurthy, Vijaya L. Dommeti, Kari Wilder-Romans, Irfan A. Asangani
Direct comparison of various BET inhibitors in prostate cancer cells.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::054e977023690453334ed18abb56aba5
https://doi.org/10.1158/1541-7786.22514317
https://doi.org/10.1158/1541-7786.22514317
Autor:
Evan T. Keller, Atsushi Mizokami, June Escara-Wilke, Jill M. Keller, Jinlu Dai, Mary Osisami, Mi Zhang
Supplemental Figure 1. Validation of gene for chemoresistance of prostate cancer to DTX. Supplemental Figure 2. Caliper measurements of subcutaneous tumors presented in Figure 5A. Supplemental Figure 3. Bone stromal cells decrease LXN expression and
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::90ffb8670f8ed5769049096f6f4b5d43
https://doi.org/10.1158/1541-7786.22515403.v1
https://doi.org/10.1158/1541-7786.22515403.v1
Autor:
Arul M. Chinnaiyan, Felix Y. Feng, Shaomeng Wang, Nora M. Navone, Stephen R. Plymate, June Escara-Wilke, Ingrid J. Apel, Pranathi M. Krishnamurthy, Vijaya L. Dommeti, Kari Wilder-Romans, Irfan A. Asangani
De-recruitment of BRD2/3/4 from the SRSF1 and U2AF1 promoter by JQ1.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::819e8d59b6ba003ad07470d9ee744e45
https://doi.org/10.1158/1541-7786.22514314.v1
https://doi.org/10.1158/1541-7786.22514314.v1
Autor:
Arul M. Chinnaiyan, Felix Y. Feng, Shaomeng Wang, Nora M. Navone, Stephen R. Plymate, June Escara-Wilke, Ingrid J. Apel, Pranathi M. Krishnamurthy, Vijaya L. Dommeti, Kari Wilder-Romans, Irfan A. Asangani
Supplemental Materials and Methods
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::296a106703e23bc203cb887760436c4f
https://doi.org/10.1158/1541-7786.22514305
https://doi.org/10.1158/1541-7786.22514305
Autor:
Arul M. Chinnaiyan, Felix Y. Feng, Shaomeng Wang, Nora M. Navone, Stephen R. Plymate, June Escara-Wilke, Ingrid J. Apel, Pranathi M. Krishnamurthy, Vijaya L. Dommeti, Kari Wilder-Romans, Irfan A. Asangani
Antibodies and PCR Primers
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c1481eb367b7728ff991717cc9dfdedb
https://doi.org/10.1158/1541-7786.22514302
https://doi.org/10.1158/1541-7786.22514302
Autor:
Arul M. Chinnaiyan, Felix Y. Feng, Shaomeng Wang, Nora M. Navone, Stephen R. Plymate, June Escara-Wilke, Ingrid J. Apel, Pranathi M. Krishnamurthy, Vijaya L. Dommeti, Kari Wilder-Romans, Irfan A. Asangani
AR- and ERG-positive PDX model displays sensitivity to JQ1.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::080c0516542719a4a23c81835e05d5dc
https://doi.org/10.1158/1541-7786.22514311.v1
https://doi.org/10.1158/1541-7786.22514311.v1